The pragmatic use of apomorphine at the end of life

被引：13

作者：

Dewhurst, F. ^{[1
]}

Lee, M. ^{[2
]}

Wood, B. ^{[1
]}

机构：

[1] Northumbria Healthcare NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England

[2] St Benedicts Hosp Sunderland, Sunderland, Durham, England

来源：

PALLIATIVE MEDICINE | 2009年 / 23卷 / 08期

关键词：

Parkinson's disease; apomorphine; palliation; end of life care; IDIOPATHIC PARKINSONS-DISEASE; QUALITY-OF-LIFE; SUBCUTANEOUS APOMORPHINE; MANAGEMENT;

D O I：

10.1177/0269216309106979

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD. Optimising PD medication is an important aspect of end of life care. There are no previously reported cases of apomorphine providing symptom relief in terminal care of PD patients. This case highlights its potential benefits for symptom control at the end of life.

引用

页码：777 / 779

页数：3

共 20 条

[1] CONTINUOUS SUBCUTANEOUS APOMORPHINE AS REPLACEMENT FOR LEVODOPA IN SEVERE PARKINSONIAN-PATIENTS AFTER SURGERY [J].

BROUSSOLLE, E ;

MARION, MH ;

POLLAK, P .

LANCET, 1992, 340 (8823) :859-860

[2] A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease [J].

Chen, JJ ;

Obering, C .

CLINICAL THERAPEUTICS, 2005, 27 (11) :1710-1724

[3] Subcutaneous apomorphine - An evidence-based review of its use in Parkinson's disease [J].

Deleu, D ;

Hanssens, Y ;

Northway, MG .

DRUGS & AGING, 2004, 21 (11) :687-709

[4] Care of the dying patient: the last hours or days of life [J].

Ellershaw, J ;

Ward, C .

BRITISH MEDICAL JOURNAL, 2003, 326 (7379) :30-34

[5] Perioperative problems in Parkinson's disease and their management: Apomorphine with rectal domperidone [J].

GalvezJimenez, N ;

Lang, AE .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 23 (03) :198-203

[6]

Gonsalkorale M, 2005, CME GERIATRIC MED, V7, P22

[7] Measuring symptom load in Idiopathic Parkinson's disease [J].

Lee, M. A. ;

Prentice, W. M. ;

Hildreth, A. J. ;

Walker, R. W. .

PARKINSONISM & RELATED DISORDERS, 2007, 13 (05) :284-289

[8] Individualized assessment of quality of life in idiopathic Parkinson's disease [J].

Lee, Mark A. ;

Walker, Richard W. ;

Hildreth, Anthony J. ;

Prentice, Wendy M. .

MOVEMENT DISORDERS, 2006, 21 (11) :1929-1934

[9] A survey of pain in idiopathic Parkinson's disease [J].

Lee, Mark A. ;

Walker, Richard W. ;

Hildreth, Tony J. ;

Prentice, Wendy M. .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 32 (05) :462-469

[10] Practical approach to quality of life in Parkinson's disease: the nurse's role [J].

MacMahon, DG ;

Thomas, S .

JOURNAL OF NEUROLOGY, 1998, 245 (Suppl 1) :S19-S22

← 1 2 →